BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16923149)

  • 1. Behavioral and sleep/wake characteristics of mice lacking norepinephrine and hypocretin.
    Hunsley MS; Curtis WR; Palmiter RD
    Genes Brain Behav; 2006 Aug; 5(6):451-7. PubMed ID: 16923149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norepinephrine-deficient mice exhibit normal sleep-wake states but have shorter sleep latency after mild stress and low doses of amphetamine.
    Hunsley MS; Palmiter RD
    Sleep; 2003 Aug; 26(5):521-6. PubMed ID: 12938804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered sleep latency and arousal regulation in mice lacking norepinephrine.
    Hunsley MS; Palmiter RD
    Pharmacol Biochem Behav; 2004 Aug; 78(4):765-73. PubMed ID: 15301933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates.
    Willie JT; Renthal W; Chemelli RM; Miller MS; Scammell TE; Yanagisawa M; Sinton CM
    Neuroscience; 2005; 130(4):983-95. PubMed ID: 15652995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy.
    Baier PC; Hallschmid M; Seeck-Hirschner M; Weinhold SL; Burkert S; Diessner N; Göder R; Aldenhoff JB; Hinze-Selch D
    Sleep Med; 2011 Dec; 12(10):941-6. PubMed ID: 22036605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenergic signaling plays a critical role in the maintenance of waking and in the regulation of REM sleep.
    Ouyang M; Hellman K; Abel T; Thomas SA
    J Neurophysiol; 2004 Oct; 92(4):2071-82. PubMed ID: 15190089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep-wakefulness effects after microinjections of hypocretin 1 (orexin A) in cholinoceptive areas of the cat oral pontine tegmentum.
    Moreno-Balandrán E; Garzón M; Bódalo C; Reinoso-Suárez F; de Andrés I
    Eur J Neurosci; 2008 Jul; 28(2):331-41. PubMed ID: 18702704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-amplitude theta wave bursts during REM sleep and cataplexy in hypocretin-deficient narcoleptic mice.
    Bastianini S; Silvani A; Berteotti C; Lo Martire V; Zoccoli G
    J Sleep Res; 2012 Apr; 21(2):185-8. PubMed ID: 21883592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypocretin-2 saporin lesions of the ventrolateral periaquaductal gray (vlPAG) increase REM sleep in hypocretin knockout mice.
    Kaur S; Thankachan S; Begum S; Liu M; Blanco-Centurion C; Shiromani PJ
    PLoS One; 2009 Jul; 4(7):e6346. PubMed ID: 19623260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral state instability in orexin knock-out mice.
    Mochizuki T; Crocker A; McCormack S; Yanagisawa M; Sakurai T; Scammell TE
    J Neurosci; 2004 Jul; 24(28):6291-300. PubMed ID: 15254084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal activity of orexin and non-orexin waking-active neurons during wake-sleep states in the mouse.
    Takahashi K; Lin JS; Sakai K
    Neuroscience; 2008 May; 153(3):860-70. PubMed ID: 18424001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of cardiovascular variability during undisturbed wake-sleep behavior in hypocretin-deficient mice.
    Silvani A; Bastianini S; Berteotti C; Lo Martire V; Zoccoli G
    Am J Physiol Regul Integr Comp Physiol; 2012 Apr; 302(8):R958-64. PubMed ID: 22357806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of corticotropin-releasing hormone type-2 receptor alters sleep responses to bacterial lipopolysaccharide in mice.
    Jakubcakova V; Flachskamm C; Deussing JM; Kimura M
    Brain Behav Immun; 2011 Nov; 25(8):1626-36. PubMed ID: 21704697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D(1)/D(2) receptor-targeting L-stepholidine, an active ingredient of the Chinese herb Stephonia, induces non-rapid eye movement sleep in mice.
    Qiu MH; Qu WM; Xu XH; Yan MM; Urade Y; Huang ZL
    Pharmacol Biochem Behav; 2009 Nov; 94(1):16-23. PubMed ID: 19604496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GABAA receptor agonist THIP alters the EEG in waking and sleep of mice.
    Vyazovskiy VV; Kopp C; Bösch G; Tobler I
    Neuropharmacology; 2005 Apr; 48(5):617-26. PubMed ID: 15814097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders.
    Parmentier R; Anaclet C; Guhennec C; Brousseau E; Bricout D; Giboulot T; Bozyczko-Coyne D; Spiegel K; Ohtsu H; Williams M; Lin JS
    Biochem Pharmacol; 2007 Apr; 73(8):1157-71. PubMed ID: 17288995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prepro-hypocretin (prepro-orexin) expression is unaffected by short-term sleep deprivation in rats and mice.
    Terao A; Peyron C; Ding J; Wurts SW; Edgar DM; Heller HC; Kilduff TS
    Sleep; 2000 Nov; 23(7):867-74. PubMed ID: 11083595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical effects of the hypnotic Zolpidem in the neonatal ferret.
    Hsu N; Jha SK; Coleman T; Frank MG
    Behav Brain Res; 2009 Jul; 201(1):233-6. PubMed ID: 19428639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective stimulation of orexin receptor type 2 promotes wakefulness in freely behaving rats.
    Akanmu MA; Honda K
    Brain Res; 2005 Jun; 1048(1-2):138-45. PubMed ID: 15919057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The behavioral effects of L-methionine and related compounds in rats and mice.
    Beaton JM; Smythies JR; Bradley RJ
    Biol Psychiatry; 1975 Feb; 10(1):45-52. PubMed ID: 164253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.